WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced revenues of $13.8 million for its fourth quarter of 2009. For 2009, the company reported positive adjusted EBITDA, a non-GAAP measure, of $1.6 million, an improvement of $7.2 million.
